imiquimod
Generic: imiquimod
Labeler: glenmark pharmaceuticals inc., usaDrug Facts
Product Profile
Brand Name
imiquimod
Generic Name
imiquimod
Labeler
glenmark pharmaceuticals inc., usa
Dosage Form
CREAM
Routes
Active Ingredients
imiquimod 50 mg/g
Manufacturer
Identifiers & Regulatory
Product NDC
68462-536
Product ID
68462-536_be827b5b-c3e8-4ec3-a8b0-a745e29f8ebc
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
ANDA
Application Number
ANDA201994
Listing Expiration
2027-12-31
Marketing Start
2012-03-06
Pharmacologic Class
Mechanism of Action
Physiologic Effect
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
68462536
Hyphenated Format
68462-536
Supplemental Identifiers
RxCUI
UNII
NUI
Packaging Origin
Original Packager
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
imiquimod (source: ndc)
Generic Name
imiquimod (source: ndc)
Application Number
ANDA201994 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 50 mg/g
Packaging
- 24 PACKET in 1 CARTON (68462-536-70) / .25 g in 1 PACKET (68462-536-01)
Packages (1)
Ingredients (1)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["TOPICAL"], "spl_id": "be827b5b-c3e8-4ec3-a8b0-a745e29f8ebc", "openfda": {"nui": ["N0000009267", "N0000009269", "N0000000157"], "unii": ["P1QW714R7M"], "rxcui": ["310982"], "spl_set_id": ["663e39a9-a29e-473f-89ec-4c7c6bc27b8a"], "pharm_class_pe": ["Increased Cytokine Activity [PE]", "Increased Cytokine Production [PE]"], "pharm_class_moa": ["Interferon Inducers [MoA]"], "manufacturer_name": ["Glenmark Pharmaceuticals Inc., USA"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "24 PACKET in 1 CARTON (68462-536-70) / .25 g in 1 PACKET (68462-536-01)", "package_ndc": "68462-536-70", "marketing_start_date": "20120306"}], "brand_name": "Imiquimod", "product_id": "68462-536_be827b5b-c3e8-4ec3-a8b0-a745e29f8ebc", "dosage_form": "CREAM", "pharm_class": ["Increased Cytokine Activity [PE]", "Increased Cytokine Production [PE]", "Interferon Inducers [MoA]"], "product_ndc": "68462-536", "generic_name": "Imiquimod", "labeler_name": "Glenmark Pharmaceuticals Inc., USA", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Imiquimod", "active_ingredients": [{"name": "IMIQUIMOD", "strength": "50 mg/g"}], "application_number": "ANDA201994", "marketing_category": "ANDA", "marketing_start_date": "20120306", "listing_expiration_date": "20271231"}